LAY, LUIGI
 Distribuzione geografica
Continente #
EU - Europa 8.009
NA - Nord America 7.004
AS - Asia 6.787
SA - Sud America 643
AF - Africa 185
OC - Oceania 24
Continente sconosciuto - Info sul continente non disponibili 7
Totale 22.659
Nazione #
US - Stati Uniti d'America 6.800
CN - Cina 2.013
GB - Regno Unito 2.009
IT - Italia 1.995
SG - Singapore 1.955
SE - Svezia 818
DE - Germania 804
RU - Federazione Russa 651
VN - Vietnam 574
HK - Hong Kong 511
BR - Brasile 469
IN - India 455
FR - Francia 414
TR - Turchia 361
NL - Olanda 350
IE - Irlanda 230
KR - Corea 229
UA - Ucraina 202
BD - Bangladesh 196
FI - Finlandia 173
JP - Giappone 118
CA - Canada 100
ID - Indonesia 94
EU - Europa 91
CI - Costa d'Avorio 78
AR - Argentina 59
DK - Danimarca 59
MX - Messico 59
BE - Belgio 49
PL - Polonia 48
CO - Colombia 47
PH - Filippine 46
ES - Italia 41
PK - Pakistan 38
CH - Svizzera 33
SA - Arabia Saudita 31
ZA - Sudafrica 30
TW - Taiwan 26
IQ - Iraq 25
AT - Austria 24
MA - Marocco 24
GR - Grecia 21
AU - Australia 19
EC - Ecuador 16
PT - Portogallo 15
EG - Egitto 14
UZ - Uzbekistan 14
CL - Cile 13
KE - Kenya 13
NO - Norvegia 13
MY - Malesia 12
VE - Venezuela 12
PE - Perù 11
MD - Moldavia 10
TH - Thailandia 10
CZ - Repubblica Ceca 9
NP - Nepal 9
RO - Romania 9
AE - Emirati Arabi Uniti 7
CU - Cuba 7
IL - Israele 7
IR - Iran 7
JO - Giordania 7
KZ - Kazakistan 7
DZ - Algeria 6
JM - Giamaica 6
BO - Bolivia 5
CR - Costa Rica 5
KG - Kirghizistan 5
LT - Lituania 5
PY - Paraguay 5
SK - Slovacchia (Repubblica Slovacca) 5
A2 - ???statistics.table.value.countryCode.A2??? 4
AL - Albania 4
AZ - Azerbaigian 4
BG - Bulgaria 4
ET - Etiopia 4
HN - Honduras 4
NZ - Nuova Zelanda 4
AM - Armenia 3
BH - Bahrain 3
BS - Bahamas 3
HR - Croazia 3
MO - Macao, regione amministrativa speciale della Cina 3
OM - Oman 3
RS - Serbia 3
SV - El Salvador 3
UY - Uruguay 3
BB - Barbados 2
BY - Bielorussia 2
DO - Repubblica Dominicana 2
GT - Guatemala 2
GY - Guiana 2
KW - Kuwait 2
KY - Cayman, isole 2
LB - Libano 2
LV - Lettonia 2
MW - Malawi 2
NG - Nigeria 2
PR - Porto Rico 2
Totale 22.712
Città #
Southend 1.808
Singapore 1.094
Milan 991
Ashburn 597
Chandler 483
Hong Kong 470
Dallas 435
San Jose 430
Seattle 381
Beijing 373
Hanover 282
Council Bluffs 275
Princeton 270
Dublin 224
Wilmington 222
Fairfield 207
Mountain View 195
Dearborn 190
Ann Arbor 181
Los Angeles 177
Ho Chi Minh City 173
Santa Clara 145
Redmond 143
Hanoi 137
Lauterbourg 124
Woodbridge 114
Guangzhou 110
Hefei 109
Jacksonville 106
Moscow 105
Nanjing 102
Boardman 98
New York 97
Bengaluru 94
Des Moines 94
Frankfurt am Main 93
Buffalo 88
Houston 84
Sakarya 81
Abidjan 78
Cambridge 71
Shanghai 63
Munich 55
Redwood City 53
The Dalles 53
Columbus 52
Tokyo 52
Jakarta 51
Jinan 49
Serra 48
Seoul 47
Rome 46
Tianjin 45
Phoenix 44
Somerville 44
Shenyang 42
São Paulo 42
Berlin 40
Bogotá 40
Cangzhou 38
Istanbul 38
Andover 37
Brussels 37
San Diego 37
Changsha 35
Helsinki 35
Shenzhen 33
Hangzhou 32
Eitensheim 31
Medford 31
Da Nang 28
Warsaw 28
Lappeenranta 27
Nanchang 27
Pisa 26
Wuhan 26
Chicago 25
Hebei 25
Paris 25
Bühl 23
Florence 23
Haiphong 23
London 22
Pune 21
Fuzhou 20
Kent 20
Rio de Janeiro 20
Montreal 19
Toronto 19
Dong Ket 18
Jiaxing 18
Zhengzhou 18
Athens 17
Jeddah 17
Naples 17
Silver Spring 17
Washington 17
Xiamen 17
Kunming 16
San Francisco 16
Totale 13.416
Nome #
A NEW PROCEDURE FOR THE SYNTHESIS OF AZASUGARS 667
A stabilized glycomimetic conjugate vaccine inducing protective antibodies against Neisseria meningitidis serogroup A 481
Combined chemical synthesis and tailored enzymatic elongation provide fully synthetic and conjugation-ready Neisseria meningitidis serogroup X vaccine antigens 341
Synthesis and biological evaluation of a trisaccharide repeating unit derivative of Streptococcus pneumoniae 19A capsular polysaccharide 338
Preparation and immunogenicity of gold glyco-nanoparticles as antipneumococcal vaccine model 332
Recent advances on smart glycoconjugate vaccines in infections and cancer 307
Factors affecting T cell responses induced by fully synthetic glyco-gold-nanoparticles 304
GLUCOSE-DERIVED IONIC LIQUIDS: EXPLORING LOW-COST SOURCES FOR NOVEL CHIRAL SOLVENTS 302
Vaccini antibatterici glicoconiugati: sintesi di fosfono analoghi di frammenti del polisaccaride capsulare del N. meningitidis tipo A 290
Emerging glyco-based strategies to steer immune responses 289
Vaccini antibatterici glicoconiugati : sintesi di analoghi stabilizzati di frammenti del polisaccaride capsulare del N. meningitidis tipo A 271
Carbohydrate-derived ionic liquids : Exploring the chiral pool for novel reaction media 263
Exploring glycosylation reactions under continuous-flow conditions 263
Influence of surface coating on the intracellular behaviour of gold nanoparticles : a fluorescence correlation spectroscopy study 251
Modeling of synthetic phosphono and carba analogues of N-acetyl-alpha-D-mannosamine 1-phosphate, the repeating unit of the capsular polysaccharide from Neisseria meningitidis serovar A 246
NMR evidence for the participation of triflated ionic liquids in glycosylation reaction mechanisms 243
Gold nanoparticle-based platforms for vaccine development 242
Design, preparation and biological evaluation of a small library of compounds containing the common disaccharide of Streptococcus pneumoniae 19F and 19A capsular polysaccharides 241
Carbohydrates and Immunology : Synthetic Oligosaccharide Antigens for Vaccine Formulation 239
The Conformation of the Mannopyranosyl Phosphate Repeating Unit of the Capsular Polysaccharide of Neisseria meningitidis Serogroup A and Its Carba-Mimetic 236
Glycan Array Evaluation of Synthetic Epitopes between the Capsular Polysaccharides from Streptococcus pneumoniae 19F and 19A 233
Novel carbohydrate-based bifunctional organocatalysts for nucleophilic addition to nitroolefins and imines 232
Glucose-derived ionic liquids: exploring low-cost sources for novel chiral solvents 230
Glycosylation with trichloroacetimidates in ionic liquids: influence of the reaction medium on the stereochemical outcome 230
Glycosylation with trichloroacetimidates in ionic liquids: a "green" approach to the synthesis of glycosides 230
HRMAS NMR analysis in neat ionic liquids : a powerful tool to investigate complex organic molecules and monitor chemical reactions 222
Exploiting the cross-metathesis reaction in the synthesis of pseudo-oligosaccharides 222
Recent Advances in the Synthesis of Glycoconjugates for Vaccine Development 220
Design, preparazione e valutazione biologica di una piccola collezione di composti contenenti il disaccaride comune alle capsule polisaccaridiche di Streptococcus pneumoniae 19F e 19A 217
Synthesis of stabilized analogues of fragments of Neisseria meningitidis type A capsular polysaccharide 215
Synthesis of Fragment of beta-Glucans as Potential Ligands for Dectin-1 215
Synthesis and biological evaluation of phosphono analogues of Neisseria meningitidis A capsular polysaccharide fragments. 214
Probing specific protein recognition by size-controlled glycosylated cyclodextrin nanoassemblies 213
(alpha-L-rhamnopyranosyl)methylphosphonic acids : experimental evidence of the analogy with alpha-L-rhamnopyranosyl phosphate 212
Simple synthesis of versatile coumarin scaffolds 209
Glycoporphyrin catalysts for efficient C-H bond aminations by organic azides 205
Gold nanoparticles as carriers of streptococcus pneumoniae carbohydrate antigens fully synthetic vaccines 204
Fluidic Manufacture of Star-Shaped Gold Nanoparticles 204
Synthesis of the phosphono analogue of the dimeric subunit of Neisseria meningitidis type A capsular polysaccharide 202
Iron and Ruthenium Glycoporphyrins: Active Catalysts for the Synthesis of Cyclopropanes and Aziridines 201
Impact of ConcanavalinA affinity in the intracellular fate of Protein Corona on Glucosamine Au nanoparticles 198
Synthesis of phosphorylated fragments of Streptococcus pneumoniae type 19F capsular polysaccharide 195
Efficient Synthesis of O-, S-, N- and C-Glycosides of 2-Amino-2-Deoxy-D-Glucopyranose from Glycosyl Iodides 192
Photo-Induced Microfluidic Production of Ultrasmall Glyco Gold Nanoparticles 190
Synthesis, molecular dynamics simulations, and biology of a carba-analogue of the trisaccharide repeating unit of Streptococcus pneumoniae 19F capsular polysaccharide 190
Gold nanoparticles morphology does not affect the multivalent presentation and antibody recognition of Group A Streptococcus synthetic oligorhamnans 188
Synthesis of phosphono analogues of fragments of Neisseria meningitidis type A capsular polysaccharide 186
A small library of compounds, containing the common disaccharide of Streptococcus pneumoniae 19F and 19A capsular polysaccharides, as novel non-natural antibacterial saccharide antigens 185
Synthesis of a Structural Analogue of the Repeating Unit from Streptococcus pneumoniae 19F Capsular Polysaccharide Based on the Cross-Metathesis−Selenocyclization Reaction Sequence 184
Synthesis and immunological evaluation of protein conjugates of neisseria meningitidis X capsular polysaccharide fragments 181
Major advances in the development of synthetic oligosaccharide-based vaccines 181
Multivalent, Saccharide-Functionalized Gold Nanoparticles as Fully Synthetic Analogs of Type A Neisseria meningitidis Antigens 180
Cyclodextrin nanoaggregates and their assembly with protein: a spectroscopic investigation 179
Synthesis of neisseria meningitidis x capsular polysaccharide fragments 179
Synthesis and Preliminary Biological Evaluation of Carba Analogues from Neisseria meningitidis A Capsular Polysaccharide 179
Immunoactivity of Protein Conjugates of Carba Analogues from Neisseria meningitidis A Capsular Polysaccharide 177
Functional Polarization of Liver Macrophages by Glyco Gold Nanoparticles 174
Combining cross-coupling reaction and Knoevenagel condensation in the synthesis of glyco-BODIPY probes for DC-SIGN super-resolution bioimaging 174
Identification of O-sulphate substituents on D-glucuronic acid units in heparin-related glycosaminoglycans using novel synthetic disaccharide standards 173
Expeditious synthesis of water-soluble, monolayer-protected gold nanoparticles of controlled size and monolayer composition 167
Efficient Synthesis of Unsymmetrical Ureido-Linked Disaccharides 167
Semisynthetic Glycoconjugates as Potential Vaccine Candidates Against Haemophilus influenzae Type a 165
Easy chemo-enzymatic synthesis of human milk trisaccharides from a common selectively protected lactose building block 162
Synthesis of C-disaccharides through dimerization of exo-glycals 162
Solution Synthesis of Two Orthogonally Protected Lactosides as Tetravalent Disaccharide-Based Scaffolds 161
A convenient multigram preparation of functionalized 2-azido-2-deoxy-D-mannose as a useful orthogonally protected building block for oligosaccharide synthesis 158
SYNTHETIC STUDIES ON ALPHA-C-GLYCOSIDES OF D-GLUCOSAMINE 157
Compounds 154
Elucidating the role of N-acetylglucosamine in Group A Carbohydrate for the development of an effective glycoconjugate vaccine against Group A Streptococcus 153
Antibacterial Carbohydrate Vaccines 152
Synthesis of di- and tri-saccharide fragments of Salmonella typhi Vi capsular polysaccharide and their zwitterionic analogues 152
Phosphorylation of the Synthetic Hexasaccharide Repeating Unit Is Essential for the Induction of Antibodies to Clostridium difficile PSII Cell Wall Polysaccharide 151
Synthesis of Lewis A and Lewis X pentasaccharides based on N-trichloroethoxycarbonyl protection 150
A Synthetic Disaccharide Analogue from Neisseria meningitidis A Capsular Polysaccharide Stimulates Immune Cell Responses and Induces Immunoglobulin G (IgG) Production in Mice When Protein-Conjugated 149
Trichloroacetimidates as glycosyl donors in recyclable ionic liquids 149
Stable Antibacterial glycoconjugate vaccines: Synthesis of phosphono analogues of fragments of Neisseria meningitidis type A capsular polysaccharide 148
GLYCOSYL SULFATES AS GLYCOSYL DONORS 148
A strategy for multivalent presentation of carba analogues from N. meningitidis A capsular polysaccharide 148
Synthesis of carba-analogues of n-acetyl-d-mannosamine suitable for conjugation to superparamagnetic iron oxide nanoparticles (spion) 147
Oligosaccharides Related to Tumor-Associated Antigens. Part I. Synthesis of the propyl glycoside of the trisaccharide α-L-Fucp-(1 → 2)-β-D-Galp-(1 → 3)-β-D-GalpNAc, component of a tumor antigen recognized by the antibody MBr1 147
Exploring new methods to control the stereoselectivity of glycosylation reactions 146
Gold nanoparticles functionalized with ABO blood sugar antigen as nanotools for biomedical applications 145
Boranophosphate diesters as stable synthetic analogues of 1-O-glycosylphosphates 143
Synthesis of fragments of salmonella Typhi capsular polysaccharide and their zwitterionic analogues 143
Synthesis of antimetabolites of sucrose 140
Synthetic approach to Kdo glycosides via exo-glycal epoxides and rationalization of the stereo chemical outcome 138
Immunobiology of Carbohydrates: Implications for Novel Vaccine and Adjuvant Design Against Infectious Diseases 138
A simple access to lactose-derived building blocks required in glycoconjugate synthesis 137
Chemical contributions to understanding heparin activity: Synthesis of related sulfated oligosaccharides 136
Amphiphilic N-glycosyl-thiocarbamoyl cyclodextrins: synthesis, selfassembly and fluorimetry of recognition by Lens culinaris lectin. 135
Stereoselective synthesis of the isosteric phosphono analogues of N-acetyl-alpha-D-glucosamine 1-phosphate and N-acetyl-alpha-D-mannosamine 1-phosphate 135
Synthesis of fragments of Salmonella Typhi capsular polysaccharide and their zwitterionic analogues 134
SYNTHETIC GLYCOSAMINOGLYCAN PENTASACCHARIDES FOR INHIBITION OF ENZIMATIC ACTIVITY OF HEPARANASE 133
Synthesis of Neisseria meningitidis X capsular polysaccharide fragments 131
HPLC-Based Automated Synthesis and Purification of Carbohydrates 129
Regioselective acylation of disaccharides by enzymatic transesterification 129
Synthesis of N-acetylglucosamine containing Lewis A and Lewis X building blocks based on N-tetrachlorophthaloyl protection - Synthesis of Lewis X pentasaccharide 128
Oligosaccharides related to tumor-associate antigens. Part 3. Synthesis of the propyl glycosides of the trisaccharide β-D-Galp-(1→3)-β-D-GalpNAc-(1→3)-α-D-Galp and of the Tetrasaccharide α-L-Fucp-(1→2)-β-D-Galp-(1→3)-β-D-GalpNAc-(1→3)-α-D-Galp, components of a tumor antigen recognized by the antibody MBr1 127
A rational approach to heparin-related fragments - Synthesis of differently sulfated tetrasaccharides as potential ligands for fibroblast growth factors 126
Synthesis of disaccharidic sub-units of a new series of heparin related oligosaccharides 126
Totale 19.907
Categoria #
all - tutte 62.244
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 62.244


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021107 0 0 0 0 0 0 0 0 0 0 0 107
2021/20221.839 147 71 62 115 175 140 184 142 123 192 189 299
2022/20231.923 240 224 176 187 204 368 65 104 194 28 73 60
2023/20241.243 45 98 53 78 248 77 43 74 29 110 204 184
2024/20253.531 188 287 73 296 268 186 146 377 169 375 338 828
2025/20266.956 598 586 714 627 659 442 959 397 745 482 631 116
Totale 23.828